Atlas Trials

Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock

Clinical trial NCT01352182 · COMPLETED

Trial details

NCT number
NCT01352182
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Severe SepsisSeptic Shock
Start date
2011-10-01
Primary completion
2016-05-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.